Skip to main content
Top
Published in: Diabetologia 7/2005

01-07-2005 | Short Communication

Asymptomatic bacteriuria as a predictor of subsequent hospitalisation with urinary tract infection in diabetic adults: The Fremantle Diabetes Study

Authors: H. Karunajeewa, D. McGechie, G. Stuccio, N. Stingemore, W. A. Davis, T. M. E. Davis

Published in: Diabetologia | Issue 7/2005

Login to get access

Abstract

Aims/hypothesis

We examined the prognosis of well-characterised community-based diabetic patients with asymptomatic bacteriuria (ASB).

Methods

We studied 496 adults with type 1 or 2 diabetes participating in a prospective observational study. In addition to detailed clinical and laboratory data, a single mid-stream urine sample was taken for aerobic culture and antibiotic-sensitivity testing. ASB was defined as ≥105 colony-forming units/ml of one or two organisms without symptoms of urinary infection. Patients were followed for 2.9±0.6 years for hospital admission for/with urosepsis or death.

Results

Thirty-six patients (7.3%) had ASB, comprising 33 females (14.4% of all females) and three males (1.1% of all males). Only female sex predicted ASB amongst a range of variables including indices of metabolic control. Twenty-nine patients (5.8%) were subsequently hospitalised with urosepsis. Of these, urosepsis was the principal diagnosis in 12 (41%). In a Cox proportional hazards model, ASB was associated with an increased risk of hospitalisation for urosepsis as principal diagnosis (hazard ratio [95% CI] 4.4 [1.2–16.5]; p=0.004). ASB did not predict the combined endpoint of hospitalisation with urosepsis as principal or secondary diagnosis (2.3 [0.8–6.7]; p=0.12), or of non-urinary sepsis as principal (n=12) or principal/secondary (n=28) diagnosis (p>0.3).

Conclusions/interpretation

ASB identifies diabetic patients who are at significantly increased risk of subsequent urosepsis requiring hospitalisation. Further large-scale studies are needed to establish the cost-effectiveness of screening for, and pre-emptive treatment of ASB, especially in females.
Literature
1.
go back to reference Stapleton A (2002) Urinary tract infections in patients with diabetes. Am J Med 113(Suppl 1A):80S–84SCrossRefPubMed Stapleton A (2002) Urinary tract infections in patients with diabetes. Am J Med 113(Suppl 1A):80S–84SCrossRefPubMed
2.
go back to reference Geerlings SE, Stolk RP, Camps MJ et al (2001) Consequences of asymptomatic bacteriuria in women with diabetes mellitus. Arch Intern Med 161:1421–1427CrossRefPubMed Geerlings SE, Stolk RP, Camps MJ et al (2001) Consequences of asymptomatic bacteriuria in women with diabetes mellitus. Arch Intern Med 161:1421–1427CrossRefPubMed
3.
go back to reference Harding GK, Zhanel GG, Nicolle LE, Cheang M, Manitoba Diabetes Urinary Tract Infection Study Group (2002) Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med 347:1576–1583CrossRefPubMed Harding GK, Zhanel GG, Nicolle LE, Cheang M, Manitoba Diabetes Urinary Tract Infection Study Group (2002) Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med 347:1576–1583CrossRefPubMed
4.
go back to reference Davis TME, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR (2000) Auto-antibodies to glutamic acid decarboxylase in diabetic patients from a multiethnic Australian community: the Fremantle Diabetes Study. Diabetic Med 17:667–674CrossRefPubMed Davis TME, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR (2000) Auto-antibodies to glutamic acid decarboxylase in diabetic patients from a multiethnic Australian community: the Fremantle Diabetes Study. Diabetic Med 17:667–674CrossRefPubMed
5.
go back to reference Geerlings SE, Brouwer EC, Gaastra W, Hoepelman AI (2000) Is a second urine specimen necessary for the diagnosis of asymptomatic bacteriuria? Clin Infect Dis 31:e3–e4CrossRefPubMed Geerlings SE, Brouwer EC, Gaastra W, Hoepelman AI (2000) Is a second urine specimen necessary for the diagnosis of asymptomatic bacteriuria? Clin Infect Dis 31:e3–e4CrossRefPubMed
6.
go back to reference Gillett M, Davis WA, Jackson D, Bruce DG, Davis TME (2003) Prospective evaluation of carotid bruit as a predictor of first stroke in type 2 diabetes: The Fremantle Diabetes Study. Stroke 34:2145–2151CrossRefPubMed Gillett M, Davis WA, Jackson D, Bruce DG, Davis TME (2003) Prospective evaluation of carotid bruit as a predictor of first stroke in type 2 diabetes: The Fremantle Diabetes Study. Stroke 34:2145–2151CrossRefPubMed
7.
go back to reference Geerlings S, Stolk R, Camps M et al (2000) Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care 23:744–749PubMed Geerlings S, Stolk R, Camps M et al (2000) Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care 23:744–749PubMed
8.
go back to reference Bonadio M, Boldrini E, Forotti G et al (2004) Asymptomatic bacteriuria in women with diabetes: influence of metabolic control. Clin Infect Dis 38:e41–e45CrossRefPubMed Bonadio M, Boldrini E, Forotti G et al (2004) Asymptomatic bacteriuria in women with diabetes: influence of metabolic control. Clin Infect Dis 38:e41–e45CrossRefPubMed
9.
go back to reference Forland M, Thomas VL (1985) The treatment of urinary tract infections in women with diabetes mellitus. Diabetes Care 8:499–506PubMed Forland M, Thomas VL (1985) The treatment of urinary tract infections in women with diabetes mellitus. Diabetes Care 8:499–506PubMed
10.
go back to reference Forland M, Thomas V, Shelokov A (1977) Urinary tract infections in patients with diabetes mellitus. Studies on antibody coating of bacteria. JAMA 238:1924–1926CrossRefPubMed Forland M, Thomas V, Shelokov A (1977) Urinary tract infections in patients with diabetes mellitus. Studies on antibody coating of bacteria. JAMA 238:1924–1926CrossRefPubMed
Metadata
Title
Asymptomatic bacteriuria as a predictor of subsequent hospitalisation with urinary tract infection in diabetic adults: The Fremantle Diabetes Study
Authors
H. Karunajeewa
D. McGechie
G. Stuccio
N. Stingemore
W. A. Davis
T. M. E. Davis
Publication date
01-07-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 7/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1794-3

Other articles of this Issue 7/2005

Diabetologia 7/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine